SRBC.F Stock Overview
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Sirona Biochem Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.042 |
| 52 Week High | CA$0.12 |
| 52 Week Low | CA$0.042 |
| Beta | -0.44 |
| 1 Month Change | -13.15% |
| 3 Month Change | -48.83% |
| 1 Year Change | -58.89% |
| 3 Year Change | -86.29% |
| 5 Year Change | -78.11% |
| Change since IPO | -30.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| SRBC.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | 1.2% |
| 1Y | -58.9% | 1.1% | 24.7% |
Return vs Industry: SRBC.F underperformed the US Biotechs industry which returned 1.1% over the past year.
Return vs Market: SRBC.F underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| SRBC.F volatility | |
|---|---|
| SRBC.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SRBC.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SRBC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Howard Verrico | www.sironabiochem.com |
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009.
Sirona Biochem Corp. Fundamentals Summary
| SRBC.F fundamental statistics | |
|---|---|
| Market cap | US$12.15m |
| Earnings (TTM) | -US$1.93m |
| Revenue (TTM) | US$26.49k |
423.3x
P/S Ratio-5.8x
P/E RatioIs SRBC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SRBC.F income statement (TTM) | |
|---|---|
| Revenue | CA$36.35k |
| Cost of Revenue | CA$63.45k |
| Gross Profit | -CA$27.09k |
| Other Expenses | CA$2.63m |
| Earnings | -CA$2.65m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.01 |
| Gross Margin | -74.54% |
| Net Profit Margin | -7,297.87% |
| Debt/Equity Ratio | -84.1% |
How did SRBC.F perform over the long term?
See historical performance and comparison